References
- Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344:1688–700.
- Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001;248:612–6.
- Leone M, Chandra V, Schoenberg BS. Motor neuron disease in the United States, 1971 and 1973–1978: patterns of mortality and associated conditions at the time of death. Neurology. 1987;37:1339–43.
- Jokelainen M. The epidemiology of amyotrophic lateral sclerosis in Finland. A study based on the death certificates of 421 patients. J Neurol Sci. 1976;29:55–63.
- Gil J, Funalot B, Verschueren A, Danel-Brunaud V, Camu W, van den Berghe N, . Causes of death among French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol. 2008;15:1245–51.
- Spataro R, Lo Re M, Piccoli T, Piccoli F, La Bella V. Causes and place of death in Italian patients with amyotrophic lateral sclerosis. Acta Neurol Scand. 2010;122:217–23.
- Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, . Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9:59–62.
- Sejvar JJ, Holman RC, Bresee JS, Kochanek KD, Schonberger LB. Amyotrophic lateral sclerosis mortality in the United States, 1979–2001. Neuroepidemiology. 2005; 25:144–52.
- Ragonese P, Salemi G, Aridon P, Conte S, Cuccia G, Lupo I, . Accuracy of death certificates for motor neuron disease and multiple sclerosis in the province of Palermo in southern Italy. Neuroepidemiology. 2002;21:148–52.
- Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
- Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
- Huang R, Fang DF, Ma MY, Guo XY, Zhao B, Zeng Y, . TARDBP gene mutations among Chinese patients with sporadic amyotrophic lateral sclerosis. Neurobiol of Aging. 2010. (online.)
- Fang DF, Zhang SS, Guo XY, Zeng Y, Yang Y, Zhou D, . Clinical and genetic features of patients with sporadic amyotrophic lateral sclerosis in south-west China. Amyotroph Lateral Scler. 2009:10(5-6):350–54.
- Rabkin JG, Albert SM, del Bene ML, O'Sullivan I, Tider T, Rowland LP, . Prevalence of depressive disorders and change over time in late-stage ALS. Neurology. 2005;65: 62–7.
- Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, . Practice parameter update: the care of the patient with amyotrophic lateral sclerosis. Drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1218–26.
- Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, . Practice parameter update: the care of the patient with amyotrophic lateral sclerosis. Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) – report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1227–33.
- Sathasivam S. Managing patients with amyotrophic lateral sclerosis. Eur J Intern Med. 2009;20:355–8.
- Radunovic A, Mitsumoto H, Leigh PN. Clinical care of patients with amyotrophic lateral sclerosis. Lancet Neurol. 2007;6:913–25.
- Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999; 164:82–8.